000 01628 a2200457 4500
005 20250516201149.0
264 0 _c20141029
008 201410s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0087309
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJamal, Mohammad S
245 0 0 _aAnticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches.
_h[electronic resource]
260 _bPloS one
_c2014
300 _ae87309 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Phytogenic
_xchemistry
650 0 4 _aClass Ib Phosphatidylinositol 3-Kinase
_xchemistry
650 0 4 _aDatabases, Pharmaceutical
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMice
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Conformation
650 0 4 _aNF-kappa B
_xchemistry
650 0 4 _aNaphthoquinones
_xchemistry
650 0 4 _aProtein Binding
650 0 4 _aProto-Oncogene Proteins c-akt
_xchemistry
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xchemistry
650 0 4 _aSTAT3 Transcription Factor
_xchemistry
700 1 _aParveen, Shadma
700 1 _aBeg, Mohd A
700 1 _aSuhail, Mohd
700 1 _aChaudhary, Adeel G A
700 1 _aDamanhouri, Ghazi A
700 1 _aAbuzenadah, Adel M
700 1 _aRehan, Mohd
773 0 _tPloS one
_gvol. 9
_gno. 2
_gp. e87309
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0087309
_zAvailable from publisher's website
999 _c23601149
_d23601149